Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4011259 | 1.00 | ADRB2 (0.74) | ADRB2ADRA1D | |
| SCHEMBL4018361 | 0.93 | ADRB2 (0.73) | ADRB2ADRA1D | |
| SCHEMBL4011299 | 0.93 | ADRB2 (0.78) | ADRB2ADRA1D | |
| SCHEMBL4018353 | 0.93 | ADRB2 (0.73) | ADRB2ADRA1D | |
| SCHEMBL4011313 | 0.93 | ADRB2 (0.78) | ADRB2ADRA1D | |
| SCHEMBL4253916 | 0.92 | ADRB2 (0.75) | ADRB2ADRA1D | |
| SCHEMBL4253912 | 0.92 | ADRB2 (0.75) | ADRB2ADRA1D | |
| SCHEMBL4019825 | 0.92 | ADRB2 (0.69) | ADRB2 | |
| SCHEMBL4019815 | 0.92 | ADRB2 (0.69) | ADRB2 | |
| SCHEMBL13939646 | 0.91 | ADRB2 (0.81) | ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7482487-B2 | Phenylaminoethanol derivatives as β2 receptor agonists | PFIZER INC (US) | 2009-01-27 | — | — | US | disclosed |
| US-20070264262-A1 | Phenylaminoethanol Derivates as Beta 2 Receptor Agonists | BROWN ALAN D | 2007-11-15 | — | — | US | disclosed |
| EP-1577292-A1 | Phenylaminoethanol derivatives as beta2 receptor agonists | Pfizer Limited (GB) | 2005-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070264262-A1 | Phenylaminoethanol Derivates as Beta 2 Receptor Agonists | ADRB2, ADRB1, ADRA2C | ADRB2 1/4885ADRA1D 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.